Concetta Ragone
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · 76 works · 781 citations · h-index 17
Top works
- Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
- Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
- Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma
- Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
- Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches
- Molecular mimicry and cancer vaccine development
- 1331 Cancer vaccine development based on molecular mimicry
- HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine
- Melanoma and immunotherapy bridge 2015
- Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
- Novel Molecular Targets for Hepatocellular Carcinoma
- Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells
- Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
- Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
- Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells
- The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells
- Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion
- Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy
- Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity
- Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case